Are ticagrelor and prasugrel an alternative in the antiplatelet treatment of ischemic stroke?

Czech version

Published in: Cesk Slov Neurol N 2019; 82(6): 615
Category:

Sources

1. Johnston SC, Amarenco P, Albers P et al. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med 2016; 375(1): 35–43. doi: 10.1056/ NEJMoa1603060.

2. Ogawa A, Toyoda K, Kitagawa K et al. Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I). Lancet Neurol 2019; 18(3): 238–247. doi: 10.1016/ S1474-4422(18)30449-6.

3. Tapp L, Shantsila E, Lip GY. Role of ticagrelor in clopidogrel nonresponders: resistance is futile? Circulation 2010; 121(10): 1169–1171. doi: 10.1161/ CIR.0b013e3181d8d929.

4. Wallentin L, Becker RC, Budaj A et al. PLATO investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361(11): 1045–1057. doi: 10.1056/ NEJMoa0904327.

5. Wiviott SD, Braunwald E, McCabe CH et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357(20): 2001–2015. doi: 10.1056/ NEJMoa070648.

6. Huang DY, Eisert WG. CHANCE Trial: early short-term dual antiplatelet treatment for stroke prevention. Stroke 2013; 44(12): 3623–3624. doi: 10.1161/ STROKEAHA.113.003380.

7. Johnston SC, Easton JD, Farrant M et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 2018; 379(3): 215–225. doi: 10.1056/ NEJMoa1800410.

8. Flechtenmacher N, Kämmerer F, Dittmer R et al. Clopidogrel resistance in neurovascular stenting: correlations between light transmission aggregometry, verifynow, and the multiplate. AJNR AM J Neuroradiol 2015; 36(10): 1953–1958. doi: 10.3174/ ajnr.A4388.

9. Olafson EM, DeGrote JR, Drofa A et al. A Case series of 18 patients receiving ticagrelor after carotid stenting. J Pharm Pract 2018; 31(5): 519–521. doi: 10.1177/ 0897190017729524.

10. Shariff U, Hassan AE, Qureshi A et al. Safety and effectiveness of ticagrelor in patients with clopidogrel resistance undergoing angioplasty, stent or flow diverter placement. Stroke 2018; 49 (Suppl 1): 49. doi: 10.1161/ str.49.suppl_1.TP84.